Interesting points re the extra food lines to drive revenue however the voluntary human trials for MS sound incredibly promising as does the imminent production of Pharmocann products through the Biohealth facility for worldwide distribution.
Milestones to look forward to: - Advancing Partnership deals - Research - MS human trial results - Distribution pathways - Revenue increase
For someone who was running a mining company you cannot underestimate the people & partnerships that have been brought together under the umbrella of CGB in the medical cannabis & hemp markets ....so kudos to him for doing this in a reasonably quick timeline with quality people to drive each business division. As previous, mining is a tough gig but what Shalom & co have done to push into hemp/mm to become the largest player in Oz (hemp wise) was a bold & I believe great move to drive short & long term revenue & hopefully profit for shareholders in the near term.
CGB Price at posting:
2.5¢ Sentiment: Buy Disclosure: Held
